APA citiranje

Gotesman, M., Vo, T. T., Herzog, L., Tea, T., Mallya, S., Tasian, S. K., . . . Fruman, D. A. (2018). mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL. Oncotarget.

Citação norma Chicago

Gotesman, Moran, Thanh-Trang T. Vo, Lee-Or Herzog, Tiffeny Tea, Sharmila Mallya, Sarah K. Tasian, Marina Konopleva, and David A. Fruman. "MTOR Inhibition Enhances Efficacy of Dasatinib in ABL-rearranged Ph-like B-ALL." Oncotarget 2018.

MLA citiranje

Gotesman, Moran, et al. "MTOR Inhibition Enhances Efficacy of Dasatinib in ABL-rearranged Ph-like B-ALL." Oncotarget 2018.